On April 12, 2024, Daniel Donovan resigned from the Audit Committee of the Board of Directors of Intensity Therapeutics, Inc. prior to the Company entering into a non-material transaction with a service organization controlled by Mr. Donovan. Mr. Donovan remains on the Board and a member of the Board?s Compensation Committee and Nominating and Corporate Governance Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.84 USD | -2.81% | -3.20% | -43.52% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.52% | 68.27M | |
+48.67% | 58.71B | |
-2.76% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.25% | 26.55B | |
-23.10% | 18.98B | |
+1.88% | 12.51B | |
+26.43% | 12.08B | |
+21.74% | 11.94B |
- Stock Market
- Equities
- INTS Stock
- News Intensity Therapeutics, Inc.
- Intensity Therapeutics, Inc. Announces Resignation of Daniel Donovan from Audit Committee of the Board of Directors